105 related articles for article (PubMed ID: 18361029)
1. Use of unapproved medicines in anaesthesia practice in New Zealand.
Warmington A
Anaesth Intensive Care; 2008 Mar; 36(2):281. PubMed ID: 18361029
[No Abstract] [Full Text] [Related]
2. A survey of the use of unapproved medicines in anaesthesia practice in New Zealand.
Julian KA; Stapelberg F
Anaesth Intensive Care; 2008 Jan; 36(1):102-6. PubMed ID: 18326141
[TBL] [Abstract][Full Text] [Related]
3. Access to new medicines in New Zealand compared to Australia.
Wonder M; Milne R
N Z Med J; 2011 Nov; 124(1346):12-28. PubMed ID: 22143849
[TBL] [Abstract][Full Text] [Related]
4. A critical first assessment of the new pre-market approval regime for new psychoactive substances (NPS) in New Zealand.
Wilkins C
Addiction; 2014 Oct; 109(10):1580-6. PubMed ID: 24529166
[TBL] [Abstract][Full Text] [Related]
5. The role of the Therapeutic Goods Administration and the Medicine and Medical Devices Safety Authority in evaluating complementary and alternative medicines in Australia and New Zealand.
Ghosh D; Skinner M; Ferguson LR
Toxicology; 2006 Apr; 221(1):88-94. PubMed ID: 16481089
[TBL] [Abstract][Full Text] [Related]
6. New psychoactive substances: issues about the new approach from New Zealand government.
von Diemen L
Addiction; 2014 Oct; 109(10):1588-9. PubMed ID: 25163704
[No Abstract] [Full Text] [Related]
7. How safe is anaesthesia in New Zealand?
Gibbs JM
N Z Med J; 1989 Feb; 102(862):79-80. PubMed ID: 2919021
[No Abstract] [Full Text] [Related]
8. The use of propofol for anaesthesia in children under the age of 3 years in New Zealand.
Foy J; Nel P; Watts S
N Z Med J; 1998 Jun; 111(1067):217. PubMed ID: 9673641
[No Abstract] [Full Text] [Related]
9. To prohibit or regulate psychoactive substances: has New Zealand got the right approach?
Rizwan SB; Vernall AJ
BMJ; 2017 Mar; 356():j1195. PubMed ID: 28314708
[No Abstract] [Full Text] [Related]
10. Regulatory framework for the availability and use of animal drugs in the United States.
Modric S
Vet Clin North Am Small Anim Pract; 2013 Sep; 43(5):1005-12. PubMed ID: 23890234
[TBL] [Abstract][Full Text] [Related]
11. Cloak and Dagger? Statutory Privilege for Quality Activities in New Zealand.
Duggal M
J Law Med; 2016; 24(1):252-66. PubMed ID: 30136786
[TBL] [Abstract][Full Text] [Related]
12. Where is the pleasure?
Ritter A
Addiction; 2014 Oct; 109(10):1587-8. PubMed ID: 25163703
[No Abstract] [Full Text] [Related]
13. Confidence in competence: legislation and nursing in New Zealand.
Vernon R; Chiarella M; Papps E
Int Nurs Rev; 2011 Mar; 58(1):103-8. PubMed ID: 21281301
[TBL] [Abstract][Full Text] [Related]
14. New Zealand deserves better. Direct-to-consumer advertising (DTCA) of prescription medicines in New Zealand: for health or for profit?
Toop L; Richards D; Saunders B
N Z Med J; 2003 Aug; 116(1180):U556; discussion U556. PubMed ID: 14581976
[No Abstract] [Full Text] [Related]
15. [Earlier value assessment of pharmaceutical products and medical science].
Selbmann HK
Nervenarzt; 2016 Apr; 87(4):353-5. PubMed ID: 27000270
[No Abstract] [Full Text] [Related]
16. The FDA takes action against unapproved drugs.
Meadows M
FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
[TBL] [Abstract][Full Text] [Related]
17. Unapproved prescription cough, cold, and allergy drug products: recent US Food and Drug Administration regulatory action on unapproved cough, cold, and allergy medications.
Ostroff C; Lee CE; McMeekin J
Chest; 2011 Aug; 140(2):295-300. PubMed ID: 21813527
[TBL] [Abstract][Full Text] [Related]
18. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
Simon LS; Green A
J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
[TBL] [Abstract][Full Text] [Related]
19. Unapproved drugs--the drug information pharmacists' perspective.
Giouroukakis M; Dryer M
J Pharm Pract; 2013 Apr; 26(2):112-9. PubMed ID: 23459285
[TBL] [Abstract][Full Text] [Related]
20. Herbal medicines: challenges in the modern world. Part 1. Australia and New Zealand.
Barnes J; McLachlan AJ; Sherwin CM; Enioutina EY
Expert Rev Clin Pharmacol; 2016 Jul; 9(7):905-15. PubMed ID: 27070431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
